Bringhen S - Search Results

1

Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension.

Bringhen S, Milan A, D'Agostino M, Ferri C, Wäsch R, Gay F, Larocca A, Offidani M, Zweegman S, Terpos E, Goldschmidt H, Cavo M, Ludwig H, Driessen C, Auner HW, Caers J, Gramatzki M, Dimopoulos MA, Boccadoro M, Einsele H, Sonneveld P, Engelhardt M. Bringhen S, et al. J Intern Med. 2019 Jul;286(1):63-74. doi: 10.1111/joim.12882. Epub 2019 Apr 8. J Intern Med. 2019. PMID: 30725503 Free article.

2

Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients.

Palumbo A, Triolo S, Argentino C, Bringhen S, Dominietto A, Rus C, Omedè P, Tarella C, Pileri A, Boccadoro M. Palumbo A, et al. Among authors: bringhen s. Blood. 1999 Aug 15;94(4):1248-53. Blood. 1999. PMID: 10438712 Free article. Clinical Trial.

3

Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support.

Boccadoro M, Omedé P, Dominietto A, Palumbo A, Bringhen S, Giaretta F, Ortolano B, Triolo S, Pileri A. Boccadoro M, et al. Among authors: bringhen s. Bone Marrow Transplant. 2000 Jan;25(1):25-9. doi: 10.1038/sj.bmt.1702085. Bone Marrow Transplant. 2000. PMID: 10654010

4

Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma.

Palumbo A, Giaccone L, Bertola A, Pregno P, Bringhen S, Rus C, Triolo S, Gallo E, Pileri A, Boccadoro M. Palumbo A, et al. Among authors: bringhen s. Haematologica. 2001 Apr;86(4):399-403. Haematologica. 2001. PMID: 11325646 Clinical Trial.

5

Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma.

Boccadoro M, Palumbo A, Bringhen S, Merletti F, Ciccone G, Richiardi L, Rus C, Bertola A, Giaccone L, Omedè P, Musto P. Boccadoro M, et al. Among authors: bringhen s. Haematologica. 2002 Aug;87(8):846-50. Haematologica. 2002. PMID: 12161361

6

Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2)).

Palumbo A, Bringhen S, Bertola A, Cavallo F, Falco P, Massaia M, Bruno B, Rus C, Barbui A, Caravita T, Musto P, Pescosta N, Rossini F, Vignetti M, Boccadoro M. Palumbo A, et al. Among authors: bringhen s. Leukemia. 2004 Jan;18(1):133-8. doi: 10.1038/sj.leu.2403196. Leukemia. 2004. PMID: 14586481 Clinical Trial.

7

Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma.

Palumbo A, Bertola A, Falco P, Rosato R, Cavallo F, Giaccone L, Bringhen S, Musto P, Pregno P, Caravita T, Ciccone G, Boccadoro M. Palumbo A, et al. Among authors: bringhen s. Hematol J. 2004;5(4):318-24. doi: 10.1038/sj.thj.6200403. Hematol J. 2004. PMID: 15297848 Clinical Trial.

8

Thalidomide in front line treatment in multiple myeloma: serious risk of venous thromboembolism and evidence for thromboprophylaxis.

Rus C, Bazzan M, Palumbo A, Bringhen S, Boccadoro M. Rus C, et al. Among authors: bringhen s. J Thromb Haemost. 2004 Nov;2(11):2063-5. doi: 10.1111/j.1538-7836.2004.00931.x. J Thromb Haemost. 2004. PMID: 15550053 Free article. Clinical Trial. No abstract available.

9

Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma.

Palumbo A, Avonto I, Bruno B, Ambrosini MT, Bringhen S, Cavallo F, Falco P, Boccadoro M. Palumbo A, et al. Among authors: bringhen s. Eur J Haematol. 2006 Apr;76(4):273-7. doi: 10.1111/j.1600-0609.2005.00610.x. Eur J Haematol. 2006. PMID: 16519697 Clinical Trial.

10

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.

Palumbo A, Bringhen S, Caravita T, Merla E, Capparella V, Callea V, Cangialosi C, Grasso M, Rossini F, Galli M, Catalano L, Zamagni E, Petrucci MT, De Stefano V, Ceccarelli M, Ambrosini MT, Avonto I, Falco P, Ciccone G, Liberati AM, Musto P, Boccadoro M; Italian Multiple Myeloma Network, GIMEMA. Palumbo A, et al. Among authors: bringhen s. Lancet. 2006 Mar 11;367(9513):825-31. doi: 10.1016/S0140-6736(06)68338-4. Lancet. 2006. PMID: 16530576 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters